Glooko

Diabnext is a digital diabetes management company based in Paris, Ile-de-France, that offers a comprehensive application designed to enhance the management of pre-diabetes and diabetes. The application automatically monitors insulin and blood glucose levels, facilitating the recording of these metrics in a self-monitoring logbook. By combining hardware and software, Diabnext provides a solution that enhances the accuracy and efficiency of patient education and monitoring. The platform enables both patients and healthcare professionals to access vital data, allowing for improved tracking and management of diabetes. With features such as injection follow-ups, reminders for blood glucose checks, and medication adherence, Diabnext aims to reduce the medico-economic burden associated with diabetes-related complications while promoting better health outcomes for patients.

xbird GmbH is a medical artificial intelligence company based in Berlin, Germany, founded in 2015. The company specializes in developing algorithms that analyze micro-movements detected by sensors in smartphones and wearables. These algorithms interpret daily activities and significant events that affect patients' health, particularly focusing on diabetes management. By capturing data streams from various devices, xbird's software personalizes therapies to improve health outcomes. This approach allows caregivers to identify potential health risks and optimize long-term treatment plans, fostering a holistic care model for patients.

Diasend AB is a company specializing in diabetes data management, providing a system that allows users to upload and consolidate information from glucose meters, insulin pumps, continuous glucose monitoring (CGM) devices, and mobile applications. Its main offerings include the diasend system, which generates comprehensive reports, diasend Clinic for healthcare providers to collect and store patient data, and diasend Personal for individuals with diabetes to upload their device data. Additionally, Diasend offers an electronic medical record (EMR) interface that ensures interoperability by integrating data from various diabetes management devices into healthcare providers' systems. Founded in 2004 and originally known as Aidera AB, the company changed its name in 2012 and is headquartered in Askim, Sweden, with additional locations in Chicago and Barcelona. Diasend's solutions are FDA approved and CE marked, and the company operates in 23 countries, facilitating easier access to diabetes management information for patients and healthcare professionals alike.

Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.